APP and amyotrophic lateral sclerosis: By being reduced, it prevents APP processing (Teranishi et al., 2015) and the interaction between SOD1 and APP, which are known to lead to synaptic dysfunctions and associated neuroinflammation and neurodegeneration events in ALS (Rabinovich-Toidman et al., 2015).